Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

cipla ltd. - kapsula

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

cipla ltd. - kapsula

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

mabxience research sl - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastiski līdzekļi - alymsys in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. alymsys in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. alymsys in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with alymsys in combination with capecitabine. alymsys, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. alymsys, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. alymsys in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. alymsys, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. alymsys, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

cipla ltd. ,mumbai central, mumbai 400 008 vai shree baidyanath ayurved bhwan pvt. ltd., 1 gupta lane, kolkata -700 006 - cits, džems

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

cipla ltd. - šķidrums

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

cipla ltd. - cits, mīkstā želatīna kapsula

Latvija - latviešu - Zāļu valsts aģentūra

teva pharma b.v., netherlands - cisplatīns - koncentrāts infūziju šķīduma pagatavošanai - 0,5 mg/ml

Latvija - latviešu - Zāļu valsts aģentūra

exeltis baltics uab, lithuania - dutasteridum, tamsulosini hydrochloridum - kapsula, cietā - 0,5 mg/0,4 mg

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

gilead sciences ireland uc - emtricitabine - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - hiv-1 inficētiem pieaugušajiem un bērniem kopā ar citām aktīvajām vielām antiretrovirālā ārstēšana ir norādīts emtriva. Šī norāde ir balstīta uz pētījumiem apstrāde-naivi pacientu un ārstniecības pieredzējuši pacientiem ar stabilu virusoloģijas kontrole. nav pieredzes par lietošanu emtriva pacientiem, kuri nespēj savu pašreizējo režīmu, vai kuras nav izdevies vairākus režīmus. lemjot par jaunu režīmu pacientiem, kuriem ir failed antiretrovirālo režīms, būtu rūpīgi jāapsver modeļos mutācijas, kas saistītas ar dažādām zālēm un ārstēšanas vēstures individuāla pacienta. ja pieejams, izturības testēšana var būt lietderīgi.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

gilead sciences ireland uc - emtricitabine, tenofovir disoproxil fumarate - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - treatment of hiv-1 infection: , truvada is indicated in antiretroviral combination therapy for the treatment of hiv-1 infected adults. , truvada ir arī norādīts par attieksmi pret hiv-1 inficētiem pusaudžiem, ar nrti pretestības vai toksicitātes rādītājs, kas liedz izmantot pirmās līnijas pārstāvji, vecumā no 12 līdz 18 gadiem. , pre-exposure prophylaxis (prep): , truvada is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk.